Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Company receives certification of four drug dosage forms at new manufacturing facility
Subscribe to our email newsletter
China Aoxing Pharmaceutical (China Aoxing) has received the Good Manufacturing Practice (GMP) re-certification of four dosage forms, including capsule, tablet, granule and oral solution formulations, at its new manufacture and packaging facility.
The company said that the certificate of compliance has a five-year term and was issued by the State Food and Drug Administration (SFDA) following a site inspection.
Zhenjiang Yue, chairman and CEO of China Aoxing, said: “We are very pleased to obtain the GMP re-certification of four dosage forms, which is an important milestone in the process of our production facility consolidation.
“The re-certification will serve as a critical step to alleviate product backlog associated with these dosage forms. In addition, we expect more GMP re-certification of pill and tincture dosage forms at our brand new product facility in the first half of year 2010.”
Good Manufacturing Practice is a body of internationally accepted regulations set forth by drug agencies in many countries. GMP compliance ensures that pharmaceuticals, active ingredients and medical devices are produced and quality-controlled according to standards.